Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Welcome
Go
Free Newsletter Sign Up

Scilex, Set to Go Public, Sues Apotex to Block ZTlido Copies (1)

June 23, 2022, 5:58 PMUpdated: June 23, 2022, 8:17 PM

Sorrento Therapeutics Inc.’s Scilex unit, which plans to go public via merger with a blank-check company, alleges that a generic version of ZTlido proposed by an Apotex Inc. subsidiary infringes three patents for the treatment of lasting pain caused by a shingles infection, according to a federal lawsuit in Florida.

The formulation of the copycat proposed by Apotex’s Aveva Drug Delivery Systems Inc. unit “comprises components that perform substantially the same function, in substantially the same way, to achieve the same result” as the formulation covered by the patents, according to a complaint filed Wednesday in the US District ...